Severe adverse immunologic reaction in a patient with glioblastoma receiving autologous dendritic cell vaccines combined with GM-CSF and dose-intensified temozolomide. [electronic resource]
Producer: 20160125Description: 320-5 p. digitalISSN:- 2326-6074
- Antineoplastic Agents, Alkylating -- adverse effects
- Autoantibodies -- biosynthesis
- Cancer Vaccines -- adverse effects
- Combined Modality Therapy
- Dacarbazine -- adverse effects
- Dendritic Cells -- immunology
- Glioblastoma -- immunology
- Granulocyte-Macrophage Colony-Stimulating Factor -- adverse effects
- Humans
- Male
- Middle Aged
- Temozolomide
No physical items for this record
Publication Type: Case Reports; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.